Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-Inducible Factor-1alpha and -2alpha in Colon Cancer
Cancer Research, 11/03/09
Kikuchi H et al. – The data reveal that oncogenic KRAS and BRAF mutations differentially regulate the hypoxic induction of HIF–1alpha and HIF–2alpha in colon cancer, and this may potentially contribute to the phenotypic differences of KRAS and BRAF mutations in colon tumors.
Related Articles
Unusual Metals Could Forge New Cancer Drug
ScienceDaily, 10/20/09
Relevance Score: 70%
Management of Primary Colon Cancer in Older Adults
Geriatrics & Aging, 10/12/09
Relevance Score: 70%
Estimated dose to the rectum and colon in prostate cancer patients treated with exclusive radiation therapy presenting a secondary colorectal malignancy
Clinical Oncology, 10/07/09
Relevance Score: 70%
Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2
Molecular Cancer, 10/02/09
Relevance Score: 70%
Plasma enterolactone and risk of colon and rectal cancer in a case–cohort study of Danish men and women
Cancer Causes and Control, 10/28/09
Relevance Score: 69%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Journal of Clinical Oncology, 11/24/09
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
Molecular Cancer, 11/24/09
Expression of metalloproteases and their inhibitors in different histological types of breast cancer
Journal of Cancer Research & Clinical Oncology, 11/24/09
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
Molecular Cancer, 11/24/09
Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study
Journal of Clinical Oncology, 11/23/09
The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer
Journal of Cancer Research & Clinical Oncology, 11/23/09
Sponsor
Article Search
Sponsor
Sponsor


See All


